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A NEW LOOK at CANCER
CARE DISPARITIES
THE DEATH RATE FROM CANCER IS NOTABLY HIGHER FOR AFRICAN
Americans than Caucasians, which derives from
disparities in screening, diagnosis, engagement in
clinical trials and therapeutic efficacy and less use of
hospice and palliative care among African Americans.
“The causes of these complex disparities reflect
social, cultural and economic inequalities more
than biological differences,” says Lisa WhitfieldHarris, PhD, MSN, MBA, assistant professor of
nursing. “Addressing them effectively will require
interventions that are developed in full partnership
with the African American community.”
She and two Jefferson colleagues—Clara GrandaCameron, DrNP, MSN, assistant professor of
nursing, and Jeannette Kates, PhD, CRNP,
assistant professor of nursing and director of the
adult-gerontology primary care nurse practitioner
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program—are collaborating on two studies that
seek to clarify and begin addressing culturally
based reasons for cancer care disparities within
the African American population.

Promoting African American Engagement
in Clinical Trials
The first study seeks to address the fact that—
despite researchers’ increasing efforts over
the past 25 years—African Americans continue
to be underrepresented in clinical trials. This
underrepresentation means that trial results
often do not accurately gauge a treatment’s
effectiveness for African Americans.
“Through this project, called Empowerment
Through Engagement: African Americans as
Partners in Clinical Trials, we will develop a
culturally sensitive teaching tool to promote African
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American community advocacy and engagement
in clinical trials,” says Dr. Granda-Cameron.
The study is a partnership between the Jefferson
researchers and the cancer survivors’ organization,
Sisters R Us Circle of Survivors. It will use a
community-based participatory research design
and Freire’s dialogue approach to explore
participants’ perceptions about participating
in clinical trials, as well as concepts of racism,
discrimination, resiliency and protective factors.
The results will then be employed as the basis for
collaborative development of the teaching tool.

Advance Care Planning among African
Americans Diagnosed with Cancer
The second project explores perceptions of advance
care planning among African Americans who have
been diagnosed with cancer. “There is consistent

evidence that African Americans are less likely to
engage in goals-of-care discussions, complete
advance directives or enroll in hospice or palliative
care,” says Dr. Kates.
Funded by a research grant from the provost’s
office, the project is using three structured
instruments and follow-up conversations to
measure and understand mistrust, decisional
control preference and advance care planning
readiness among study participants.
“Our goal is to use the information we gather
in this study to create a culturally sensitive and
highly effective intervention that helps increase
the number of African Americans who engage in
advance cancer care planning,” explains Dr. Kates. 
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